In January, activist investor Nelson Peltz's Trian Fund Management said in a letter to Solventum shareholders that the company's spin-off from 3M had not been living up to potential. Trian ...
M spin-off Solventum forecast annual profit above analyst estimates on Thursday, betting on strong sales of its wound care and surgical sterilization products.
The most notable increase was Solventum Corp (NYSE:SOLV), with an additional 1,336,564 shares, bringing the total to 8,462,819 shares. This adjustment represents a significant 18.76% increase in share ...
Its stock is up 12% so far this year. Solventum Corporation (NYSE:SOLV) is a spinoff from 3M Company (MMM) and is currently facing activist investor pressure. Nelson Peltz, a billionaire ...
Nelson Peltz’s Trian Fund Management disclosed in an SEC filing its holdings as of December 31, 2024. Trian increased its stake in a number of ...
Unilever's board, which includes billionaire activist investor Nelson Peltz, was unified in its decision to oust CEO Hein ...